TIDES USA: Oligonucleotide and Peptide Therapeutics

San Diego, CA, USA
May 11–14, 2026

Meet Genedata Experts at TIDES USA in San Diego, CA, USA.

Don't miss the opportunity to see how Genedata digitalizes and automates data-rich and complex biopharma R&D processes. From early discovery all the way to the clinic, Genedata solutions maximize the ROI in R&D expenditure.

To schedule a meeting in advance or receive more information on Genedata, please contact us.

Visit Our Poster Session:

Poster: Fully Automated Candidate Creation Workflow for Intact Mass Mapping of Oligonucleotide Therapeutics
We present a fully automated oligonucleotide candidate creation workflow for intact mass mapping that offers unparalleled flexibility and analysis control by enabling users to define individual building blocks such as linkers, bases, and sugars and create customized nucleotide candidates for clips, modifications, insertions, and deletions. 
This eliminates manual work and leads to the generation of comprehensive search libraries to be used for identification and monitoring of oligonucleotide candidates
 

Poster: Screen Smarter, Not Harder: Automating Hit Selection Across RT‑qPCR, RNA-seq and Beyond
We developed Screener, a specialized software solution that automates quality control, analysis, and reporting across diverse screening modalities, including high‑throughput RNA‑seq, RT‑qPCR, and high‑content assays. Automated QC, standardized feature extraction, and integrated hit ranking enable faster, reproducible identification of high‑quality oligonucleotide hits while maintaining full data traceability. 
By structuring complex screening datasets in a consistent and scalable manner, Screener supports confident hit selection and ensures data integrity for downstream modeling workflows.